{
    "title": "BRIEF-Sanofi Says Dupixent Shows Reduction In Exacerbations In Phase 3 Trial As A Potential Treatment For COPD",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-11893359/BRIEF-Sanofi-Says-Dupixent-Shows-Reduction-In-Exacerbations-In-Phase-3-Trial-As-A-Potential-Treatment-For-COPD.html",
    "date": "2023-03-23",
    "keywords": [
        "phase",
        "trial",
        "dupixent",
        "placebo",
        "sanofidupixent",
        "reduction",
        "ml",
        "safety",
        "march",
        "treatment",
        "sanofiphase",
        "use",
        "improvement",
        "lung",
        "function",
        "fev1",
        "disease",
        "evidence",
        "type",
        "inflammation",
        "quality",
        "life",
        "respiratory",
        "profile",
        "sanofisafety",
        "efficacy",
        "itepekimab",
        "authority",
        "sanofiadverse",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}